The independent source for health policy research, polling, and news.
The Debate About Enhanced Premium Tax Credits Begins to Emerge (Finally)
In his latest column, president and CEO Drew Altman discusses why debate about extending the ACA enhanced tax credits set to expire this year has been slow to develop, and why it could matter to Republicans politically if the tax credits are not extended.
Beyond the Data Read PostDecoding the HHS Reorganization
In his latest column, KFF President and CEO Drew Altman examines the implications of Secretary Kennedy’s reorganization of HHS and why it’s a sharp break from past efforts to reorganize the department.
Beyond the Data Read PostWhy Most States Will Not Replace Federal Medicaid Cuts
In his latest Beyond the Data column, KFF’s President and CEO Drew Altman discusses how difficult it will be for states to replace lost federal Medicaid funding should Congress make significant cuts.
Beyond the Data Read PostTrump Voters On Medicaid, On Medicaid Cuts
In a new column, KFF President and CEO Drew Altman discusses how recent KFF focus groups with Trump voters on Medicaid show that voters were not expecting big Medicaid cuts from the Trump administration and worry about what the impact of potential cuts in federal Medicaid spending will be. As Drew writes: “Trump built a populist base of working people formerly in the Democratic party.” When details of specific Medicaid cuts emerge, tension could develop between “Trump and Republicans on the Hill who want to cut entitlement programs that now serve a significant part of Trump’s base.”
Beyond the Data Read PostThe Two Big Decisions That Will Drive Health Policy
KFF’s president and CEO Drew Altman writes in a new column about the factors driving the biggest health policy decisions now—how to pay for tax cuts and whether President Trump wants another big fight about health care.
Beyond the Data Read PostCould Trump Walk Away from Unpopular Health Proposals?
In a new column, KFF President and CEO Drew Altman discusses what President Trump’s decision to pull back the broad freeze in federal grant funding might portend for his response to future policies in health that prove controversial or unpopular.
Beyond the Data Read Post